Category:BTK inhibitors

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 21:55, 22 January 2021 by Jwarner (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

A class of drugs that inhibit Bruton's tyrosine kinase (BTK). The first specific drug approved in this class is Ibrutinib (Imbruvica), although Dasatinib (Sprycel) has some demonstrated degree of BTK inhibition[1].

References

  1. ↑ The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13283-8. Epub 2007 Aug 7.
Retrieved from "https://hemonc.org/w/index.php?title=Category:BTK_inhibitors&oldid=46984"